Company intelligence / Profile preview

International Virotherapy Center

Ownership
Private
Development stage
Commercial
01

Overview

International Virotherapy Center coordinates access to virotherapy using the ECHO‑7 Rigvir oncolytic virus. Retrospective studies report prolonged survival and improved quality of life for patients with late-stage melanoma, small cell lung cancer, and histiocytic sarcoma treated with this therapy. In Latvia, approximately 75% of melanoma patients are treated with Rigvir. The product has been included in national guidelines there but remains unapproved or available only under special access programs elsewhere.

Therapeutic areas
Oncology
Modalities
Oncolytic viruses (notably ECHO‑7 Rigvir)live virus-based therapies and supplements
Industry
Biotech
02

Drug pipeline

1 asset

rigvir

Commercial
Indications
Melanoma, Kidney cancer, Uterine cancer, Lung cancer, Colorectal cancer
03

Partnerships

Previously part of partnerships/licensing deals involving development/commercialization with Sinorda Biomedicine (China) and Smart Nanovirus Limited (UK); also collaborates closely with Global Virotherapy Cancer Clinic and International Virotherapy Association.

Beyond the preview

Go deeper on International Virotherapy Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Virotherapy Center.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call